NIH awards $22M for Biomedical R&D to UC San Francisco over 10 years
Contract Overview
Contract Amount: $22,039,342 ($22.0M)
Contractor: Regents of the University of California, SAN Francisco, the
Awarding Agency: Department of Health and Human Services
Start Date: 2003-09-30
End Date: 2013-12-05
Contract Duration: 3,719 days
Daily Burn Rate: $5.9K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 2
Pricing Type: COST NO FEE
Sector: R&D
Official Description: BIOMEDICAL (BASIC)
Place of Performance
Location: SAN FRANCISCO, SAN FRANCISCO County, CALIFORNIA, 94103
Plain-Language Summary
Department of Health and Human Services obligated $22.0 million to REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE for work described as: BIOMEDICAL (BASIC) Key points: 1. Significant 10-year contract for fundamental biomedical research. 2. Competition was full and open, suggesting market-driven pricing. 3. Potential risk associated with long-term, basic research funding. 4. Sector focus is R&D, a critical area for national health.
Value Assessment
Rating: good
The contract's cost-plus-no-fee structure for basic research is typical. Benchmarking is difficult without specific deliverables, but the duration suggests a stable, long-term investment.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
Full and open competition was utilized, allowing multiple bidders to propose solutions. This method generally leads to better price discovery and value for the government.
Taxpayer Impact: Taxpayer funds are invested in advancing scientific knowledge, with potential long-term benefits for public health and innovation.
Public Impact
Supports critical advancements in biomedical science. Fosters innovation through long-term research funding. Potential for groundbreaking discoveries impacting public health.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Long contract duration may not adapt to evolving research needs.
- Basic research outcomes are inherently uncertain.
Positive Signals
- Full and open competition ensures market responsiveness.
- Stable funding supports long-term scientific inquiry.
Sector Analysis
This contract falls within the Research and Development sector, specifically focusing on physical, engineering, and life sciences. Spending in this area is crucial for innovation and national competitiveness.
Small Business Impact
No specific indication of small business participation was provided in the data. Larger institutions like universities often lead such research efforts.
Oversight & Accountability
The contract was awarded by the National Institutes of Health, a major federal agency with established oversight mechanisms for research grants and contracts.
Related Government Programs
- Research and Development in the Physical, Engineering, and Life Sciences
- Department of Health and Human Services Contracting
- National Institutes of Health Programs
Risk Flags
- Long-term commitment to basic research carries inherent uncertainty.
- Potential for scope creep or evolving research priorities over a decade.
- Difficulty in directly measuring ROI for fundamental scientific discovery.
Tags
research-and-development-in-the-physical, department-of-health-and-human-services, ca, definitive-contract, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $22.0 million to REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE. BIOMEDICAL (BASIC)
Who is the contractor on this award?
The obligated recipient is REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE.
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (National Institutes of Health).
What is the total obligated amount?
The obligated amount is $22.0 million.
What is the period of performance?
Start: 2003-09-30. End: 2013-12-05.
What specific research milestones or deliverables were expected under this contract?
The provided data does not detail specific research milestones or deliverables. As a basic research contract, the focus is likely on advancing scientific understanding rather than predefined outputs. Further review of the contract's statement of work would be necessary to ascertain specific expectations and track progress effectively.
How was the 'cost no fee' structure evaluated for fairness and value?
The 'cost no fee' structure typically means the contractor is reimbursed for allowable costs but receives no additional profit. For basic research, this can be appropriate as it incentivizes efficient cost management. Value is assessed through the scientific merit of the proposed research and the reputation of the performing institution.
What is the long-term impact of this $22M investment on biomedical innovation?
A $22 million investment over ten years in basic biomedical research has the potential for significant long-term impact. It can lead to fundamental discoveries that form the basis for future medical treatments, diagnostic tools, and a deeper understanding of diseases, ultimately benefiting public health and the economy.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in the Physical, Engineering, and Life Sciences
Product/Service Code: RESEARCH AND DEVELOPMENT › N – Health R&D Services
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Offers Received: 2
Pricing Type: COST NO FEE (S)
Evaluated Preference: NONE
Contractor Details
Parent Company: State of California Controllers Office (UEI: 071549000)
Address: 1855 FOLSOM ST STE 425, SAN FRANCISCO, CA, 94103
Business Categories: Category Business, Educational Institution, Government, Higher Education, Nonprofit Organization, Not Designated a Small Business, U.S. Regional/State Government
Financial Breakdown
Contract Ceiling: $34,905,074
Exercised Options: $22,039,342
Current Obligation: $22,039,342
Contract Characteristics
Commercial Item: COMMERCIAL ITEM PROCEDURES NOT USED
Timeline
Start Date: 2003-09-30
Current End Date: 2013-12-05
Potential End Date: 2013-12-05 00:00:00
Last Modified: 2018-09-13
More Contracts from Regents of the University of California, SAN Francisco, the
- Novation From Cpic to Ucsf Effect. 8/01/18--Surveillance, Epidemiology, and END Results (seer) Program, POP: 05/01/2018-04/30/2028 — $36.9M (Department of Health and Human Services)
- Biomedical (applied/Exploratory) — $27.0M (Department of Health and Human Services)
- Sexually Transmitted Infections Clinical Trials Group — $26.6M (Department of Health and Human Services)
- Biomedical (applied/Exploratory) — $16.2M (Department of Health and Human Services)
- R&d-Other R & D-B RES — $13.6M (Department of Health and Human Services)
View all Regents of the University of California, SAN Francisco, the federal contracts →
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →